REVATIS REGENERATIVE MEDICINE AND CELL THERAPY
LIVE

Serial Number

90553103

Owner

REVATIS S.A.

Attorney

Nicholas D. Wells

Filing Date

Mar 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

REVATIS REGENERATIVE MEDICINE AND CELL THERAPY Trademark

Serial Number: 90553103 • Registration: 6742715

REVATIS REGENERATIVE MEDICINE AND CELL THERAPY is a trademark filed by REVATIS S.A. on March 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

REVATIS S.A. (3 trademarks)

Liège B344000 , BE

Entity Type: 99

Trademark Details

Filing Date

March 1, 2021

Registration Date

May 31, 2022

Published for Opposition

March 15, 2022

Goods & Services

Cell cryopreservation services

Pharmaceutical products for regenerative medicine; orthopedic articles, namely, lubricating gel

Veterinary services; Beauty and hygiene care services for animals; Skin care services being hygiene and beauty care; medical services

Medical apparatus and instruments for veterinary purposes and for use in surgery as it relates to regenerative medicine; cell culture apparatus for medical or veterinary use, namely, cell culture chambers; orthopedic articles, namely, bone prostheses, joint prostheses, medical instruments for use in performing biopsies in the nature of microbiopsies

Development of pharmaceutical products; development of cell therapy products; development of technologies for the manufacture and processing of cells for use in advanced cell therapy; Research and development of new products for others

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 31, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 31, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 23, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 10, 2022 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 8, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 8, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 8, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 8, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2022 CRFA
ASSIGNED TO LIE
Feb 1, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 1, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2021 NWOS
NEW APPLICATION ENTERED
Mar 4, 2021 NWAP